Eliem Therapeutics Price on June 28, 2024

ELYMDelisted Stock  USD 3.09  0.06  1.90%   
If you're considering investing in Eliem Stock, it is important to understand the factors that can impact its price. As of today, the current price of Eliem Therapeutics stands at 3.09, as last reported on the 18th of December 2024, with the highest price reaching 3.19 and the lowest price hitting 3.07 during the day. Eliem Therapeutics secures Sharpe Ratio (or Efficiency) of -0.34, which denotes the company had a -0.34% return per unit of risk over the last 3 months. Eliem Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Eliem Therapeutics' Variance of 23.13, mean deviation of 3.62, and Standard Deviation of 4.81 to check the risk estimate we provide.
  
Eliem Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.3426

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsELYM

Estimated Market Risk

 4.83
  actual daily
43
57% of assets are more volatile

Expected Return

 -1.66
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.34
  actual daily
0
Most of other assets perform better
Based on monthly moving average Eliem Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eliem Therapeutics by adding Eliem Therapeutics to a well-diversified portfolio.

Eliem Therapeutics Valuation on June 28, 2024

It is possible to determine the worth of Eliem Therapeutics on a given historical date. On June 28, 2024 Eliem was worth 8.0 at the beginning of the trading date compared to the closed value of 7.11. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Eliem Therapeutics stock. Still, in general, we apply an absolute valuation method to find Eliem Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Eliem Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Eliem Therapeutics' related companies.
 Open High Low Close Volume
  8.07    8.21    7.46    7.53    318,330  
06/28/2024
  8.00    8.40    7.01    7.11    1,105,245  
  7.09    7.42    6.92    7.05    43,124  
Backtest Eliem Therapeutics  |  Eliem Therapeutics History  |  Eliem Therapeutics Valuation   PreviousNext  
Open Value
8.0
7.11
Closing Value
22.50
Upside

Eliem Therapeutics Trading Date Momentum on June 28, 2024

On July 01 2024 Eliem Therapeutics was traded for  7.05  at the closing time. The top price for the day was 7.42  and the lowest listed price was  6.92 . The trading volume for the day was 43.1 K. The trading history from July 1, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.84% . The overall trading delta against the current closing price is 5.49% .

Eliem Therapeutics Fundamentals Correlations and Trends

By evaluating Eliem Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Eliem Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Eliem financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Eliem Therapeutics Stock history

Eliem Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eliem is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eliem Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eliem Therapeutics stock prices may prove useful in developing a viable investing in Eliem Therapeutics
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Eliem Therapeutics, Inc. was incorporated in 2018 and is headquartered in Redmond, Washington. Eliem Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 41 people.

Eliem Therapeutics Stock Technical Analysis

Eliem Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Eliem Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Eliem Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Eliem Therapeutics Period Price Range

Low
December 18, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Eliem Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Eliem Therapeutics December 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Eliem Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eliem Therapeutics shares will generate the highest return on investment. By undertsting and applying Eliem Therapeutics stock market strength indicators, traders can identify Eliem Therapeutics entry and exit signals to maximize returns

Eliem Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Eliem Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eliem Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eliem to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Consideration for investing in Eliem Stock

If you are still planning to invest in Eliem Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eliem Therapeutics' history and understand the potential risks before investing.
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
CEOs Directory
Screen CEOs from public companies around the world